Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders. - Wikidata - wikimedia - TriplyDB

Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.

Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.

http://www.wikidata.org/entity/Q37692383

about

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine Deep Response in Multiple Myeloma: A Critical Review Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies New criteria for response assessment: role of minimal residual disease in multiple myeloma The myeloma stem cell concept, revisited: from phenomenology to operational terms Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis.Differentiation stage of myeloma plasma cells: biological and clinical significance.Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma.Correlation between CD117+ myeloma plasma cells and hematopoietic progenitor cells in different categories of patients Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study Immunophenotypic characterization and quantification of neoplastic bone marrow plasma cells by multiparametric flow cytometry and its clinical significance in Korean myeloma patients.Flow Cytometry in Diagnosis of Myelomatous Pleural Effusion: A Case Report.Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.Differential effects of lenalidomide during plasma cell differentiation Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.Immunophenotyping in multiple myeloma and related plasma cell disorders.Association of response endpoints with survival outcomes in multiple myeloma.Immunophenotype of normal and myelomatous plasma-cell subsets The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients.The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma.Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expression.Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.Current applications of multiparameter flow cytometry in plasma cell disorders.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma.Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.Expression of TRPM8 in human reactive lymphoid tissues and mature B-cell neoplasms Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

P2860

Q24604581-ACF6DBF7-4641-432F-A902-8B545764E251 Q24605023-572AE3BB-9135-4AB9-9A0D-364F70CD9203 Q26771228-1D295EF3-9716-40EE-ADAE-4D981776B311 Q27026478-6EE86905-914C-4A2D-A4D8-223FF2FD7FE8 Q27027512-3D96E3C6-D17A-4247-88FD-A508C184615E Q28076070-216BDD94-4F5C-44EB-BCF3-7C417A4FCE1B Q33598391-049D15B4-39EA-4562-8621-510E5F5B3292 Q33712516-25721B14-0DD2-4B5D-A70F-7843F7930024 Q33786986-848DC32B-262B-4167-8E73-AAF094D7D789 Q35765157-3EDEF2F5-1111-4D60-A4D9-8EB5B7205D0B Q35963125-E1E754CC-985E-41AF-BB38-AF1863A2269B Q36525219-1FDF676A-E4F0-4DF7-A55A-2A9F3529956B Q36705534-022EF1BD-2FEE-451E-B6A7-B73B9DABDD2F Q36742324-4CB64EC2-D381-4A3A-9B48-72745C932765 Q37048434-D8DE94F8-6392-4136-98B2-44D2B37AE90B Q37216380-6035A3A8-2DD7-461A-8B1E-2A4760E20873 Q37317494-FB31CFA9-E6DB-4C1F-B478-65C53E607C0F Q37626783-4BE830DE-8C2D-4593-96F1-6657CFD7354A Q37812870-1730761B-5294-4434-9267-2AA6D755A4C1 Q38122624-5A2CEE6C-2F5B-4F2A-901A-384A787BE716 Q38641261-7D37A584-71D9-443D-B2AF-139D5C696FF9 Q38922393-3C52FD8D-B17D-4011-95FC-111E24B7CA65 Q40178024-B568166D-BA0A-4FE6-8E4C-1FA8752593BF Q40992186-0EB46FBB-7110-4544-9696-8F052A947246 Q41091821-BBB8318D-8F00-4E56-8803-560C201C3438 Q41104743-D6ABFA8F-9B37-46A5-BC3C-F0CF590391B8 Q41468587-9F0CE0A2-2496-4581-9D1A-99455A718E7A Q41522009-A8A69EF2-7EAB-4587-9829-01A4200895C3 Q41827707-02A69FD3-08A7-4F5C-AAA3-A113A7E668D4 Q46826314-3AFE4D1C-5F81-4E2C-A398-BE82E369D526 Q47110039-0A88AC92-4EE5-4BD4-821E-A41FFD3DE943 Q49641900-1D80185B-2404-49A3-A07F-E9A8D9060944 Q49869942-B14D241A-A166-415E-A58B-8715BFFB457B Q51804210-C0C95099-9A0E-43A1-8C4A-0F555E3693CE Q57788729-4F1881B7-E533-486B-B5F9-0C678D434170 Q59135626-0D75D173-86E2-4F71-A8A6-F49547C1528B

P2860

Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.

http://www.wikidata.org/entity/Q37692383

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Utility of flow cytometry immu ...... plasma cell-related disorders.

@en

Utility of flow cytometry immu ...... plasma cell-related disorders.

@nl

type

label

Utility of flow cytometry immu ...... plasma cell-related disorders.

@en

Utility of flow cytometry immu ...... plasma cell-related disorders.

@nl

prefLabel

Utility of flow cytometry immu ...... plasma cell-related disorders.

@en

Utility of flow cytometry immu ...... plasma cell-related disorders.

@nl

P1433

Q37692383-723EEEBF-3E07-4707-85E9-320615772932

P1476

Q37692383-D415538D-BE50-4C61-887A-2607F6C68B6D

P2093

Q37692383-0C025747-A1AF-4B3F-A1A2-5D9C154CE017

Q37692383-1BF74366-613E-48D5-8BEA-00590A0E69D6

Q37692383-439B36F8-CAC4-46AA-A108-33591C787D9A

Q37692383-7609645B-CD9B-4FFB-BFB2-616D2AD24BE1

Q37692383-79F288EF-0AD7-4D65-91CD-ECEEA734E1A5

Q37692383-84CD7B67-E56E-41D3-9F20-F188B20BA0CE

Q37692383-A113EFCD-9236-4829-A2C0-890D479A545C

Q37692383-BB1D5C04-4E71-4F96-A899-6552E80DBFE9

Q37692383-D8A84A49-7B1F-49B6-A840-FC282DD7D972

Q37692383-D92DD384-6F52-40B7-9C50-438901B28BB2

P2860

Q37692383-716BAC26-FAD7-4B12-8D31-FE7AED152424

Q37692383-9EEF3C35-70E2-4FF5-9CC3-3614649B7D70

P304

Q37692383-1D2BFD1E-18AC-40A5-B122-AC7FD18ECA35

P31

Q37692383-3F7DE82C-F4CA-463D-BB76-43035C875F8C

P356

Q37692383-A5C84BB0-9491-488D-8099-810EA43A94C1

P433

Q37692383-7B01A822-1DED-4655-87FA-A5CA0F05423D

P478

Q37692383-FC077FFC-1A05-444C-B553-2CF6C9BCE064

P577

Q37692383-6638CD87-18EB-4C05-9E8E-73AFCB3C6486

P5875

Q37692383-523145CF-E7FA-4DBE-9880-98A3FAAA5CD8

P698

Q37692383-8D1E406A-9B16-468A-AD2A-C01DAC384D94

P356

P1433

Cytometry Part B: Clinical Cytometry

P1476

Utility of flow cytometry immu ...... plasma cell-related disorders.

@en

P2093

Alberto Orfao

http://www.w3.org/2001/XMLSchema#string

Ana Rasillo

http://www.w3.org/2001/XMLSchema#string

Antonio López

http://www.w3.org/2001/XMLSchema#string

Bruno Paiva

http://www.w3.org/2001/XMLSchema#string

Gema Mateo

http://www.w3.org/2001/XMLSchema#string

Jesús F San Miguel

http://www.w3.org/2001/XMLSchema#string

Julia Almeida

http://www.w3.org/2001/XMLSchema#string

Martin Pérez-Andrés

http://www.w3.org/2001/XMLSchema#string

María-Belén Vídriales

http://www.w3.org/2001/XMLSchema#string

María-Consuelo López-Berges

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.

Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation

P304

239-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.B.20512

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41430238

http://www.w3.org/2001/XMLSchema#string

P698

20155853

http://www.w3.org/2001/XMLSchema#string